Live Trading News
Center

Longevity Center

Healthspan science, biotech, and the companies commercialising it.

15 articles15 cryptographically verified

Longevity has moved from fringe interest to a serious research field with real capital behind it. The useful question is no longer whether lifespan can be extended, but which interventions have evidence, which are plausible and unproven, and which are being sold well ahead of the data.

The Longevity Center is Live Trading News coverage of healthspan science and the industry forming around it: NK cells and immune function, stem cell therapy, cancer screening and early detection, metabolic health and nutrition, biological age testing, and the listed and private companies commercialising each of them.

The editorial standard is the same one applied to markets. Claims are separated from evidence, early-stage results are labelled as early-stage, and a compelling mechanism is not treated as a proven outcome. Coverage is written for people making decisions about their own health and their own capital, which is a reason for more caution rather than less.

This center is informational and not medical advice. Every article is cryptographically signed at publication and anchored to an independent ledger, so what was claimed, and when, remains verifiable.

Latest coverage